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described for each of these drugs, but 
only 1 case of Rhodococcus infection 
has been reported for a patient 
receiving methotrexate and none have 
been described for patients receiving 
rituximab (10).
Because of diffi culties in 
species identifi cation and delays 
in growth, non–R. equi  infections 
might be underdiagnosed (9). This 
fi nding is complicated by the fact 
that these gram-positive bacilli may 
be misidentifi ed as contaminating 
diphtheroids (9). It is unlikely that this 
organism was a contaminant, given 
that the fever in the patient relapsed 
after antimicrobial drugs were 
discontinued and no other cause was 
identifi ed. The isolate from the patient 
was identifi ed by sequencing the fi rst 
≈500 bp of the 16S rRNA gene, which 
is a useful molecular technique for 
speciation of the genus Rhodococcus 
(9). The isolate showed 99.8% identity 
with R. erythropolis type strain DSM 
43066.
Antimicrobial drug susceptibility 
patterns in non–R. equi rhodococci 
have not been studied, and there are 
no established standards for treating 
patients with Rhodococcus spp. 
infections. This case, along with 
previously reported cases, represents 
emergence of an opportunistic 
pathogen in a rapidly increasing 
patient population, namely those with 
impaired local or systemic immunity.
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To the Editor: Francisella 
tularensis, the etiologic agent of 
tularemia, is a highly infectious 
zoonotic agent. F. tularensis subsp. 
holarctica (type B) is found throughout 
the Northern Hemisphere and is the 
only subspecies found in Europe (1). 
Lagomorphs and rodents probably 
serve as the primary mammalian 
reservoir hosts, and hematophagous 
arthropods, such as ticks, play a role 
as vectors and hosts (2,3). Although 
F. tularensis is a potential agent 
of biological warfare and several 
emergences and reemergences of 
tularemia have been reported around 
the world (1,4), the epizootiology 
of the disease is only partially 
understood. The aim of our study was 
to analyze factors that infl uence the 
emergence of tularemia in Hungary.
The study area (15,475 km2) 
included 3 counties in eastern Hungary. 
The analyzed data represented a 
period of 25 years, March 1984–
February 2010. Annual F. tularensis–
specifi c seroprevalence data for 
the European brown hare (Lepus 
europaeus) population were obtained 
by slide agglutination testing during 
the winter (December and January) 
screening of 2,500–25,000 animals 
(online Technical Appendix, wwwnc.
cdc.gov/EID/article/18/8/11-1826-
Techapp.xls). Population density data 
(animals/km2) for hares were based on 
February line transect counts and were 
obtained from the Hungarian Game 
Management database (www.vvt.
gau.hu/vadgazdalkodasi_statisztikak.
htm). Common vole (Microtus arvalis) 
densities (calculated from the number 
of active burrows/hectare during 
November) for 1996–2010 were 
obtained from the Central Agriculture 
Offi ce, Budapest, Hungary. Vole 
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density was scaled from 0 (absent) 
to 10 (peak population). The annual 
number of tularemia cases in humans 
(based on clinical history and tube 
agglutination test results) was 
obtained from the National Center for 
Epidemiology, Budapest.
The data were regrouped according 
to the yearly biologic cycle (March–
February) for hares and voles (Figure), 
and relationships between these yearly 
data were quantifi ed by using the 
Spearman rank correlation coeffi cient 
(5) at county and regional levels. 
A 2–3 year cycle was characteristic 
for the analyzed data. A signifi cant 
positive correlation was found among 
the number of tularemia cases in 
humans and the seroprevalence of F. 
tularensis among European brown 
hares (Spearman ρ = 0.73; p<0.0001) 
and the population density of common 
voles (Spearman ρ = 0.77; p = 0.0081). 
A signifi cant negative correlation was 
found between the population density 
of hares and the seroprevalence of 
F. tularensis in hares (Spearman 
ρ = −0.41; p = 0.0365).
The comprehensive and long-
term annual data used in this study 
provide clues regarding the factors 
shaping the intraannual epizootiology 
and emergence or reemergence of 
tularemia. The European brown hare 
is moderately sensitive to F. tularensis 
subsp. holarctica. The hares produce 
a heterogeneous response to infection, 
which means that some die of 
overwhelming bacteremia and others 
survive with a protracted course of 
infection, thereby contributing to the 
maintenance of tularemia over longer 
periods and serving as useful sentinels 
of disease activity. Other studies 
have concluded that hares, together 
with infected ticks, may serve as 
disease reservoirs between epizootics 
(2,3,6,7).
However, we instead hypothesize 
that the 2–3 year cycling feature of the 
population dynamics for the common 
vole (2) determines the ecology of F. 
tularensis subsp. holarctica in eastern 
Hungary. The common vole is highly 
susceptible to F. tularensis subsp. 
holarctica (3,8). When population 
densities among voles are high, F. 
tularensis disease transmission and 
spillover to hares may be facilitated by 
stress-related aggression, cannibalism, 
and F. tularensis contamination of 
the environment by infectious body 
discharges (2). Enhanced transmission 
and spillover can expand local 
outbreaks to epizootic proportions, 
and infected hares may, in turn, further 
enhance the spread of disease through 
bacterial shedding in urine (6,7).
The disease in hares often results 
in septicemia and death (7), thus 
decreasing the population density of 
these animals. Hares and especially 
voles are also hosts for different stages 
of several tick species (2,6), so it can 
be expected, that higher numbers of 
infected rodents and lagomorphs result 
in an increased proportion of infected 
ticks and, thus, increased transmission 
of F. tularensis subsp. holarctica. It can 
be concluded that a higher number of 
infection sources in the environment 
results in elevated numbers of cases in 
humans, mainly through the handling 
and skinning of hares, but also through 
tick bites and, potentially, the inhalation 
of infectious aerosols originating from, 
for example, hay or grain.
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Figure. Correlation between the seroprevalence of Francisella tularensis in the European 
brown hare (Lepus europaeus) population, the population density of European brown 
hares and common voles (Microtus arvalis), and the number of tularemia cases in humans 
eastern Hungary, 1984–2010. Values were determined on the basis of biological years 
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To the Editor: During the past 
decade, enterobacteria that produce 
Klebsiella pneumoniae carbapene-
mase (KPC) have become established 
in the United States and countries 
in South America and Europe (1). 
In Asia, KPC was reported in the 
People’s Republic of China in 2007 (2) 
and subsequently in South Korea (3) 
and Taiwan (4). Public health agencies 
emphasize screening and strict contact 
precautions to control multidrug 
resistant Enterobacteriaceae (5). 
Routine testing for mechanisms 
of resistance facilitates detection 
of emerging carbapenem-resistant 
Enterobacteriaceae.
In Singapore’s 1,000-bed National 
University Hospital during November 
2010–January 2011, we identifi ed New 
Delhi metallo-β-lactamase 1–producing 
Enterobacteriaceae in 2 clinical 
specimens but none that produced KPC 
(I. Venkatachalam et al., unpub. data). 
We conducted a laboratory screening 
study to determine the prevalence 
and nature of carbapenem-resistant 
Enterobacteriaceae in April 2011. 
Ethics committee approval was waived 
for this study.
Testing of rectal swab samples 
is part of an established hospitalwide 
program for vancomycin-resistant 
enterococci screening. Using a scoring 
system to identify patients at high risk 
for vancomycin-resistant enterococci 
(6), we found that ≈2.5 specimens per 
100 admissions were attained each 
month. During our study, we also tested 
these samples for carbapenemase-
producing Enterobacteriaceae. 
During April–June 2011, we 
incubated specimens for 24 h in 10 
mL tryptic soy broth containing 1 
mg/L imipenem, then streaked 100 
μL of the broth onto CHROMagar 
KPC (CHROMagar, Paris, France). 
Colonies detected after 24 h 
incubation at 35°C were identifi ed 
by using MALDI-TOF MS with a 
Microfl ex LT instrument (Bruker 
Daltonik GmbH, Leipzig, Germany). 
Imipenem and meropenem MICs for 
Enterobacteriacaeae were confi rmed 
by using Etests (bioMérieux, Marcy 
l’Etoile, France). Isolates with MIC 
>2 μg/mL underwent analysis with 
Metallo-β-Lactamase Confi rmative 
Identifi cation Pack (Rosco Diag-
nostica, Taastrup, Denmark) and 
Etest MBL (bioMérieux) for metallo-
β-lactamase production. Isolates 
suspected to be producers were 
genotypically confi rmed by PCR.
Of the 201 nonduplicate samples 
processed, 79 microorganisms ex-
hibited imipenem resistance and 
were isolated on CHROMagar KPC 
(Table). Among Enterobacteriaceae, 
carbapenem MIC >2 μg/mL was 
present in 1 E. aerogenes, 2 E. cloacae, 
and 4 K. pneumoniae isolates. One 
isolate (K. pneumoniae) had a positive 
combined disk test result with a pattern 
suggestive of serine carbapenemase 
production.
We analyzed genomic DNA 
(DNeasy Blood and Tissue Kit, 
QIAGEN, Hilden, Germany) from this 
isolate by using PCR for transmissible 
carbapenem resistance markers: 
metallo-β-lactamases (VIM, IMP, and 
KHM-1), serine carbapenemases 
(KPC, GES1–5 and 7), and OXA-
48. blaKPC-specifi c primers (for-ward 
primer 5′-CGTTGACGCCCAAT
CC-3′; reverse primer 5′-ACCGCT
GGCAGCTGG-3′) generated a 390-bp 
amplicon. Full gene sequencing of 
blaKPC (forward primer 5′-ATGTCAC
TGTATCGCCGTCT-3′; reverse primer 
5 ′ -CCTAAATGTGACAGTGGT
TGG) revealed 100% homology 
to blaKPC-2 (GenBank accession no. 
FJ628167.2). Further analysis showed 
that the isolate carried extended-
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